Insel Gruppe AG  presents NeuroTec

Novel, flexible and cost-efficient technologies to improve diagnostics, monitoring and therapies of neurological disorders.


NeuroTec is part of Insel Gruppe AG, dedicated to the expansion of the Neurology Department's research program.


NeuroTec is located at sitem-insel – the Swiss Institute for Translational and Entrepreneurial Medicine in Berne. sitem-insel was created to establish, operate and develop a National Center of Excellence that assists in the transition from research findings or prototypes to marketable products.